Shopping Cart
- Remove All
- Your shopping cart is currently empty
EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the Epstein-Barr virus (EBV). It serves as a suitable epitope for CD8+ T cells, facilitating the release of IFNg. The CD8 positive cytotoxic T lymphocytes (CTL) response to EBVBZLF1 (190-197) is diverse, capable of cross-recognizing similar peptide sequences from both host self-proteins and bacterial proteins. This peptide is also utilized in research on autoimmune diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | EBVBZLF1 (190-197) is an immunodominant CEF control peptide derived from the Epstein-Barr virus (EBV). It serves as a suitable epitope for CD8+ T cells, facilitating the release of IFNg. The CD8 positive cytotoxic T lymphocytes (CTL) response to EBVBZLF1 (190-197) is diverse, capable of cross-recognizing similar peptide sequences from both host self-proteins and bacterial proteins. This peptide is also utilized in research on autoimmune diseases. |
Molecular Weight | 1003.24 |
Formula | C47H82N14O10 |
Cas No. | 200124-17-0 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.